1. Home
  2. SPTN vs EYPT Comparison

SPTN vs EYPT Comparison

Compare SPTN & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPTN
  • EYPT
  • Stock Information
  • Founded
  • SPTN 1917
  • EYPT 1987
  • Country
  • SPTN United States
  • EYPT United States
  • Employees
  • SPTN N/A
  • EYPT N/A
  • Industry
  • SPTN Food Distributors
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SPTN Consumer Discretionary
  • EYPT Industrials
  • Exchange
  • SPTN Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • SPTN 596.4M
  • EYPT 579.4M
  • IPO Year
  • SPTN N/A
  • EYPT 2005
  • Fundamental
  • Price
  • SPTN $26.57
  • EYPT $10.17
  • Analyst Decision
  • SPTN Hold
  • EYPT Strong Buy
  • Analyst Count
  • SPTN 1
  • EYPT 8
  • Target Price
  • SPTN $26.90
  • EYPT $24.75
  • AVG Volume (30 Days)
  • SPTN 1.4M
  • EYPT 814.0K
  • Earning Date
  • SPTN 08-14-2025
  • EYPT 08-06-2025
  • Dividend Yield
  • SPTN 3.28%
  • EYPT N/A
  • EPS Growth
  • SPTN N/A
  • EYPT N/A
  • EPS
  • SPTN N/A
  • EYPT N/A
  • Revenue
  • SPTN $9,652,685,000.00
  • EYPT $56,042,000.00
  • Revenue This Year
  • SPTN $6.00
  • EYPT N/A
  • Revenue Next Year
  • SPTN N/A
  • EYPT N/A
  • P/E Ratio
  • SPTN N/A
  • EYPT N/A
  • Revenue Growth
  • SPTN 0.26
  • EYPT 12.04
  • 52 Week Low
  • SPTN $17.30
  • EYPT $3.91
  • 52 Week High
  • SPTN $26.69
  • EYPT $13.99
  • Technical
  • Relative Strength Index (RSI)
  • SPTN 77.47
  • EYPT 59.31
  • Support Level
  • SPTN $26.37
  • EYPT $9.45
  • Resistance Level
  • SPTN $26.58
  • EYPT $11.69
  • Average True Range (ATR)
  • SPTN 0.13
  • EYPT 0.82
  • MACD
  • SPTN 0.07
  • EYPT -0.01
  • Stochastic Oscillator
  • SPTN 72.09
  • EYPT 54.35

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: